The article explores the global prevalence of major depressive disorder (MDD) and the shortcomings of conventional treatments. It introduces transcranial magnetic stimulation (TMS) as a promising non-drug therapy, highlighting its effectiveness and minimal side effects. Dr. Colleen Hanlon, BrainsWay’s VP of Clinical & Medical Affairs, discusses TMS’s ability to target specific brain regions and personalize treatment. Various studies support TMS’s efficacy in treating not only depression but also conditions like OCD, and smoking addiction. Patient testimonials illustrate the transformative impact of TMS. The article provides resources for locating TMS providers and emphasizes its potential to offer hope to those with treatment-resistant depression.
https://www.wddty.com/features/tms-an-effective-non-drug-treatment-for-depression/
